KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Cvs Health (CVS) Leases (2016 - 2025)

Cvs Health (CVS) has disclosed Leases for 15 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Leases rose 2.21% year-over-year to $1.6 billion, compared with a TTM value of $1.6 billion through Dec 2025, up 2.21%, and an annual FY2025 reading of $1.6 billion, up 2.21% over the prior year.
  • Leases was $1.6 billion for Q4 2025 at Cvs Health, down from $15.3 billion in the prior quarter.
  • Across five years, Leases topped out at $20.5 billion in Q1 2021 and bottomed at $1.4 billion in Q4 2021.
  • Average Leases over 5 years is $14.5 billion, with a median of $17.3 billion recorded in 2023.
  • The sharpest move saw Leases skyrocketed 1199.78% in 2022, then crashed 91.03% in 2023.
  • Year by year, Leases stood at $1.4 billion in 2021, then surged by 1199.78% to $17.9 billion in 2022, then plummeted by 91.03% to $1.6 billion in 2023, then fell by 1.06% to $1.6 billion in 2024, then grew by 2.21% to $1.6 billion in 2025.
  • Business Quant data shows Leases for CVS at $1.6 billion in Q4 2025, $15.3 billion in Q3 2025, and $15.5 billion in Q2 2025.